0001214659-23-012223.txt : 20230908
0001214659-23-012223.hdr.sgml : 20230908
20230908170413
ACCESSION NUMBER: 0001214659-23-012223
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230816
FILED AS OF DATE: 20230908
DATE AS OF CHANGE: 20230908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jones James
CENTRAL INDEX KEY: 0001490829
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33637
FILM NUMBER: 231246017
MAIL ADDRESS:
STREET 1: 2525 WEST END AVE., SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001087294
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE,
STATE: TN
ZIP: 37203
BUSINESS PHONE: 615-255-0068
MAIL ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
4
1
marketforms-62531.xml
PRIMARY DOCUMENT
X0508
4
2023-08-16
0001087294
CUMBERLAND PHARMACEUTICALS INC
CPIX
0001490829
Jones James
1600 WEST END AVENUE, SUITE 1300
NASHVILLE
TN
37203
true
false
false
false
1
Common Stock
2023-08-16
5
L
false
E
65
1.64
A
27358
D
Common Stock
2023-08-17
5
L
false
E
65
1.70
A
27423
D
Common Stock
2023-08-18
5
L
false
E
65
1.70
A
27488
D
Common Stock
2023-08-21
5
L
false
E
65
1.68
A
27553
D
Common Stock
2023-08-22
5
L
false
E
65
1.72
A
27618
D
Common Stock
2023-08-23
5
L
false
E
65
1.70
A
27683
D
Common Stock
2023-08-24
5
L
false
E
27
1.69
A
27710
D
Common Stock
2023-08-25
5
L
false
E
65
1.70
A
27775
D
Common Stock
2023-08-28
5
L
false
E
65
1.71
A
27840
D
Common Stock
2023-08-29
5
L
false
E
70
1.67
A
27910
D
Common Stock
2023-08-30
5
L
false
E
65
1.68
A
27975
D
Common Stock
2023-08-31
5
L
false
E
65
1.67
A
28040
D
The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023.
James Jones by /s/ John Hamm as attorney-in-fact
2023-09-08